Morningstar ranks the Eventide Gilead Fund Within Top Decile of All Mid-Cap Growth Mutual Funds Over The Three Year Period Ending July 1, 2011

Boston, MA, July 07, 2011 – The Eventide Gilead Fund’s no-load class (ETGLX) was ranked by Morningstar within the top decile of all U.S. mid-cap growth mutual funds among 680 funds for the three year period ending July 1, 2011.

For the three years ending June 30, 2011, the Eventide Gilead Fund generated an annualized total return of 15.50%, compared to an annualized total return of 3.51% for S&P 500. During this period, ETGLX has outperformed the S&P 500 Index by 11.99% annualized.
The following table highlights the Fund’s performance over the past three years:

As of 06/30/2011
1 month return
YTD return
1 year return
Since inception (07/08/2008) annualized return
Eventide Gilead
0.88%
13.58%
47.93%
15.50%
S&P 500
-1.67%
6.02%
30.69%
3.51%
As of 07/01/2011
1 month return
YTD return
1 year return
Since inception (07/08/2008) annualized return
Eventide Gilead
6.18%
15.33%
50.80%
15.97%
S&P 500
2.08%
7.56%
33.01%
3.69%
Mid-Cap Growth
2.55%
9.76%
42.15%
5.72%
% Rank in Category (Mid-Cap Growth)
1
5
9
1
# of Funds in Category (Mid-Cap Growth)
800
790
768
680
Growth of $ 10,000
$ 10, 618
$ 11,533
$ 15,080
$ 15,598

Expenses ratios: Gross Expenses 4.13%, Net Expenses 1.63%. The advisor has agreed to maintain the Fund’s total annual operating expenses at 1.63% until at least October 31, 2011. Inception returns are annualized.

The Eventide portfolio management team attributes the Fund’s long-term outperformance to its values-driven investment approach.

“We believe that companies that prosper best over the long-term are those that serve others. Accordingly, we invest in companies that operate with integrity and excel at creating value. Just as importantly, we avoid investing in companies that engage in predatory behavior or harm customers, society, and eventually shareholders. The result is ‘values-based investing’ and it not only gives us the potential for outperformance, it also provides a unique opportunity to invest in companies whose products and practices help create a better world,” explains Eventide portfolio manager Finny Kuruvilla, MD, PhD.

Dr. Kuruvilla continues, “We are honored that according to Morningstar we have surpassed the performance of 99% of mid-cap growth funds, a competitive category of 680 funds that includes many funds run by high quality managers at prestigious firms. The last three years have included the worst period in the markets since the Great Depression as well as a tremendous rally. Our outperformance through these tumultuous market periods is a testament to the strength of our approach. We believe that the vast majority of investors are neglecting the alpha that comes from values-based investing.”

According to co-portfolio manager David Barksdale, “Eventide actively manages the Gilead Fund in pursuit of performance that is not merely reflective of the movement of broad market indices. We believe this provides better diversification benefits for our investors and allows for a greater potential for outperformance.”

The Gilead Fund is managed by Eventide Asset Management, LLC, a Boston-based investment advisor practicing faith-based and socially responsible investing.

The performance pertains to the no-load* class. The Fund offers multiple classes of shares for which performance will differ, based upon fees and commissions. *Other expenses that apply to a continued investment in the fund are described in the Fund’s prospectus.

The S&P 500 is an index created by Standard & Poor’s and is considered to represent the performance of the stock market generally. It is not an investment product available for purchase.

Alpha is the mean performance of a fund over a time period that is not explained by price movements of a related market index.

Morningstar Mid-Cap Growth Category Description:
Category includes both mid-cap growth funds that invest in stocks of companies of all sizes, thus leading to a mid-cap profile, and those that focus on midsize companies. Normally, the Gilead Fund invests primarily in a broad range of equity securities without limitation to market capitalization.

Performance is historic and does not guarantee future results. Investment return and principal value will fluctuate with changing market conditions so that when redeemed, shares may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. To obtain the most recent month end performance information or the fund’s prospectus please call the fund, toll free at 1-877-771-EVEN (3836). You can also obtain a prospectus at www.eventidefunds.com

An investor should consider the Fund’s investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information about the Eventide Gilead Fund can be found in the Fund’s prospectus. Please read the prospectus carefully before investing. The Fund is distributed by Matrix Capital Group, Inc., New York, NY 10017.

Contacts:
The Eventide Gilead Fund
Robin John
877-771-EVEN (3836) x.55 

News › Morningstar ranks the Eventide Gilead Fund Within Top Decile of All Mid-Cap Growth Mutual Funds Over The Three Year Period Ending July 1, 2011

Mutual Funds involve risk including the possible loss of principal. Past performance does not guarantee future results.The Funds’ ethical values screening criteria could cause it to under-perform similar funds that do not have such screening criteria. The Funds can have risk related to option investing. There are special risks associated with investments in foreign companies including exposure to currency fluctuations, less efficient trading markets, political instability and differing auditing and legal standards. Because of ongoing market volatility, the Funds performance may be subject to substantial short-term changes.

The Eventide Gilead Fund & Eventide Healthcare & Life Sciences Fund can invest in smaller-sized companies which may experience higher failure rates than larger companies and they normally have a lower trading volume than larger companies. The Funds can also have risk associated with the biotechnology and pharmaceutical industry in which these companies may be heavily dependent on clinical trials with uncertain outcomes and decisions made by the U.S. Food and Drug Administration. The Funds can invest in private companies. Private investments include various risks including but not limited to lack of liquidity, capital commitment risk, and valuation risk. Private companies may not be financially profitable and have uncertain futures, subjecting them to additional risks. Investors in the Gilead Fund should be aware that companies in the technology industries have different risks including but not limited to products becoming obsolete, and entrance of competing products. Companies in the Industrial Sector also carry various risks including, but not limited to, risk related to debt loads and intense competition.

Investors in the Eventide Multi-Asset Income Fund should be aware that interest rates are at historic lows and may change at any time based on government policy. In general, the price of a fixed income security falls when interest rates rise. A rise in interest rates may result in volatility and increased redemptions, which in turn could result in the fund being forced to liquidate portfolio securities at disadvantageous prices. Longer-term securities may be more sensitive to changes in interest rates. The intermediate-term bond portion of the Fund’s portfolio may represent 0% to 100% of the Fund’s portfolio with an average duration of between two and eight years.

The Eventide Multi-Asset Income Fund may invest in other funds. If other funds are utilized, such underlying funds are subject to investment advisory and other expenses, which will be indirectly paid by the Fund. As a result, your cost of investing in the Fund will be higher than the cost of investing directly in underlying funds and may be higher than other mutual funds that do not invest in underlying funds. The Fund may invest, directly or indirectly, in “junk bonds.” Such securities are speculative investments that carry greater risks than higher quality debt securities. There are unique risks associated with REITs, MLPs, preferred stocks, convertible bonds, BDCs, and yieldcos that are covered in the Fund's prospectus and SAI. The Fund is a new mutual fund and has a limited history of operations for investors to evaluate.

An investor should consider a fund's investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information can be found in the prospectus, which can be obtained at www.eventidefunds.com or by calling 1-877-771-EVEN (3836). Please read the prospectus carefully before investing. Eventide Mutual Funds are distributed by Northern Lights Distributors, LLC, Member FINRA, which is not affiliated with Eventide Asset Management, LLC.